MONTVALE, N.J., Nov. 19, 2008 (GLOBE NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electroceutical(r) therapy systems designed to target and enhance the body’s anti-inflammatory response, today announced financial results for the second quarter of fiscal 2009 ended September 30, 2008.
